I de dobbeltblinde, placebokontrollerede undersøgelser blev 529 patienter behandlet med rasagilin 1 mg dagligt i 212 patientår, og 539 patienter fik placebo i 213 patientår.
In the double blind placebo controlled studies 529 patients were treated with rasagiline 1 mg/ day for 212 patient years and 539 patients received placebo for 213 patient years.